Literature DB >> 17251686

Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway.

Dan Li1, Li-jun Wu, Shin-ichi Tashiro, Satoshi Onodera, Takashi Ikejima.   

Abstract

We have reported that oridonin, a diterpenoid isolated from the plant Rabdosia rubescens, had apoptosis-inducing activities in many cell lines (e.g., human melanoma A375-S2, human cervical cancer HeLa, human breast adenocarcinoma MCF-7, and murine fibrosarcoma L929). In this study, we further investigated signaling events involved in oridonin-induced apoptosis in human epidermoid carcinoma A431 cells. It was found that the total tyrosine kinase activity was inhibited and the protein expressions of epidermal growth factor receptor (EGFR) and phosphorylated EGFR were decreased in oridonin-induced A431 cell apoptosis. Expression of EGFR downstream effector proteins, Grb2, Ras, Raf-1, and extracellular signal-regulated kinase (ERK), was also downregulated by oridonin. Moreover, the oridonin-induced apoptosis was augmented by the Ras inhibitor manumycin A, Raf-1 inhibitor GW5074, or ERK inhibitor PD98059, suggesting that inactivation of Ras, Raf, or ERK participates in oridonin-induced apoptosis. Taken together, oridonin-induced apoptosis in A431 cells might be through blocking EGFR and its downstream Ras/Raf/ERK signal pathway.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251686     DOI: 10.1254/jphs.fpj06016x

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  13 in total

1.  MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer.

Authors:  Wei Jiang; Ke Wei; Chunfeng Pan; Hong Li; Jing Cao; Xu Han; Yu Tang; Shichao Zhu; Weiwei Yuan; Yaozhou He; Yang Xia; Liang Chen; Yijiang Chen
Journal:  Cell Prolif       Date:  2018-08-02       Impact factor: 6.831

2.  Oridonin in combination with imatinib exerts synergetic anti-leukemia effect in Ph+ acute lymphoblastic leukemia cells in vitro by inhibiting activation of LYN/mTOR signaling pathway.

Authors:  Yong Guo; Qingqing Shan; Yuping Gong; Juan Lin; Xi Yang; Ruiqing Zhou
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

3.  Roles of ERK1/2 and PI3K/AKT signaling pathways in mitochondria-mediated apoptosis in testes of hypothyroid rats.

Authors:  Yueli Yao; Xiaoru Chang; Dong Wang; Haitao Ma; Huiling Wang; Haojun Zhang; Chengyun Li; Junling Wang
Journal:  Toxicol Res (Camb)       Date:  2018-08-27       Impact factor: 3.524

Review 4.  Targeting epidermal growth factor receptors and downstream signaling pathways in cancer by phytochemicals.

Authors:  Onat Kadioglu; Jingming Cao; Mohamed E M Saeed; Henry Johannes Greten; Thomas Efferth
Journal:  Target Oncol       Date:  2014-11-21       Impact factor: 4.493

5.  Epidermal regeneration by ent-16α, 17-dihydroxy-kauran-19-oic acid isolated from Siegesbeckia pubescens.

Authors:  S-H Sung; S-H Park; S-Y Song; S-J Lee; H-W Lee; S-H Kim; M A Lee; I-S Yoon; D-D Kim; S Kang; J-H Sung
Journal:  Cell Prolif       Date:  2011-10-13       Impact factor: 6.831

6.  Apoptosis and antimigration induction in human skin cancer cells by rhodomyrtone.

Authors:  Malatee Tayeh; Sirinun Nilwarangkoon; Chantra Tanunyutthawongse; Wilawan Mahabusarakum; Ramida Watanapokasin
Journal:  Exp Ther Med       Date:  2018-04-10       Impact factor: 2.447

Review 7.  Oridonin: targeting programmed cell death pathways as an anti-tumour agent.

Authors:  Z Liu; L Ouyang; H Peng; W-Z Zhang
Journal:  Cell Prolif       Date:  2012-12       Impact factor: 6.831

8.  Functional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. Roots.

Authors:  Kejuan Li; Yue Yu; Shuang Sun; Ye Liu; Sukant Garg; Sunil C Kaul; Zhongfang Lei; Ran Gao; Renu Wadhwa; Zhenya Zhang
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

9.  Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis.

Authors:  Yan Zhang; Li Ding; Qingfeng Ni; Ran Tao; Jun Qin
Journal:  Aging (Albany NY)       Date:  2021-06-23       Impact factor: 5.682

10.  Current research and development of chemotherapeutic agents for melanoma.

Authors:  Kyaw Minn Hsan; Chun-Chieh Chen; Lie-Fen Shyur
Journal:  Cancers (Basel)       Date:  2010-04-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.